FDA Inspection
Lupin LimitedLupin Limited – FDA Inspection, Jul 11, 2023
Record Details
This FDA Inspection record concerns Lupin Limited, with an inspection on July 11, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 17123b34-eaa9-495e-b832-4865ddc69e72
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1210103
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.194(a)(1)Sample identification and other information
- 21 CFR 211.194(a)(1)Sample identification and other information
- 21 CFR 211.194(a)(4)Complete Test Data
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lupin Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2025 | Not classified | Office of Inspections and Investigations | |
| August 8, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2018 | Not classified | Office of Inspections and Investigations | |
| May 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Lupin Limited
- FDA Inspection 1296412 - 2025-11-14
- FDA Inspection 1102191 - 2019-08-08
- FDA Inspection 1070260 - 2018-09-12
- FDA Inspection 1056627 - 2018-05-11
- FDA Inspection 1019497 - 2017-05-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.